Blake Insomnia Therapeutics

OverviewSuggest Edit

Blake Insomnia Therapeutics is a pharmaceutical company. The company operates as a provider of insomnia remedy. Blake Insomnia is focused on developing its business plan for an insomnia medication known as Zleepax. Zleepax is a sleep aid with beta blockers as an active agent.
TypePublic
Founded2012
HQNew York, US
Websiteblakeinsomnia.com

Locations

Blake Insomnia Therapeutics is headquartered in
New York, United States

Location Map

Latest Updates

Employees (est.) (Feb 2019)1(-83%)
Share Price (Oct 2017)$0.1

Blake Insomnia Therapeutics Office Locations

Blake Insomnia Therapeutics has an office in New York
New York, US (HQ)
244 5th Ave #154
Show all (1)

Blake Insomnia Therapeutics Financials and Metrics

Blake Insomnia Therapeutics Revenue

Market capitalization (31-Oct-2017)

2.8m

Closing stock price (31-Oct-2017)

0.1
Blake Insomnia Therapeutics's current market capitalization is $2.8 m.
Show all financial metrics

Blake Insomnia Therapeutics Online and Social Media Presence

Embed Graph

Blake Insomnia Therapeutics Frequently Asked Questions

  • When was Blake Insomnia Therapeutics founded?

    Blake Insomnia Therapeutics was founded in 2012.

  • How many employees does Blake Insomnia Therapeutics have?

    Blake Insomnia Therapeutics has 1 employees.

  • Who are Blake Insomnia Therapeutics competitors?

    Competitors of Blake Insomnia Therapeutics include Faes Farma, SciClone Pharmaceuticals and STADA Arzneimittel.

  • Where is Blake Insomnia Therapeutics headquarters?

    Blake Insomnia Therapeutics headquarters is located at 244 5th Ave #154, New York.

  • Where are Blake Insomnia Therapeutics offices?

    Blake Insomnia Therapeutics has an office in New York.

  • How many offices does Blake Insomnia Therapeutics have?

    Blake Insomnia Therapeutics has 1 office.